Home | Articles
Published on:September 2019
Indian Journal of Pharmaceutical Education and Research, 2019; 53(4):638-648
Original Article | doi:10.5530/ijper.53.4.125

Impact of R and D Intensity, Patents and Regulatory Filings on Export Intensity of Indian Pharmaceutical Industry

Authors and affiliation (s):

Amit Banerji1, Feroz Suri2,*

1Maulana Azad National Institute of Technology, Bhopal, Madhya Pradesh, INDIA.

2Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurugram Expressway, Faridabad, Haryana, INDIA.


R and D is necessary for growth of hi-tech sectors like pharmaceuticals and is aimed at boosting innovation. Innovation brings new products that could earn revenues to further boost R and D. Indian pharmaceutical industry earns nearly sixty percent of its revenues from exports and is a leader in global generics market with largest share of ANDA and DMF filings. Significant increase in patenting activity is also observed post India’s accession to TRIPS agreement in 1995 and subsequent introduction of product patent regime in 2005. This study aims at establishing a causal relationship amongst R and D intensity, patents, regulatory filings and export intensity. Also, the impact of these variables on export intensity of Indian pharmaceutical sector has been studied by fitting them into an econometric model. Results of the econometric analysis suggested that the current year R and D intensity had a positive and significant impact on pharmaceutical export intensity and that the lagged year regulatory filings had a positive and significant impact on export intensity of Indian pharmaceutical industry. Study concluded that creation of state-of-the-art R and D facilities and manufacturing plants (complying with US and EU norms) was aimed at developing and exporting generic drugs to regulated markets of US and Europe and Indian pharmaceutical industry had not committed enough financial resources on developing new patented products for global markets.

Key words: Indian pharmaceutical industry, R and D intensity, Export intensity, Innovation and export intensity, Patents.



Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).


Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

This question is for testing whether you are a human visitor and to prevent automated spam submissions.
1 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs